OBSTETRICS AND GYNAECOLOGY / RESEARCH LETTER
 
TOPICS
REFERENCES (18)
1.
Falcone T, Flyckt R. Clinical management of endometriosis. Obstet Gynecol 2018; 131: 557-71.
 
2.
Arnal JF, Lenfant F, Metivier R, et al. Membrane and nuclear estrogen receptor alpha actions: from tissue specificity to medical implications. Physiol Rev 2017; 97: 1045-87.
 
3.
Tang ZR, Zhang R, Lian ZX, et al. Estrogen-receptor expression and function in female reproductive disease. Cells 2019; 8: 1123.
 
4.
Falconer H, Mwenda JM, Chai DC, et al. Treatment with anti-TNF monoclonal antibody (c5N) reduces the extent of induced endometriosis in the baboon. Hum Reprod 2006; 21: 1856-62.
 
5.
Lussiana C, Guani B, Mari C, et al. Mutations and polymorphisms of the FSH Receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 2008; 63: 785-95.
 
6.
Ulloa-Aguirre A, Zariñán T, Jardón-Valadez E, Gutiérrez-Sagal R, Dias JA. Structure-function relationships of the follicle-stimulating hormone receptor. Front Endocrinol 2018; 9: 707.
 
7.
Bhartiya D, Patel H. An overview of FSH-FSHR biology and explaining the existing conundrums. J Ovarian Res 2021; 14: 144.
 
8.
Robin B, Planeix F, Sastre-Garau X, et al. Follicle-stimulating hormone receptor expression in endometriotic lesions and the associated vasculature: an immunohistochemical study. Reprod Sci 2016; 23: 885-91.
 
9.
Ponikwicka-Tyszko D, Chrusciel M, Stelmaszewska J, et al. Functional expression of FSH receptor in endometriotic lesions. J Clin Endocrinol Metab 2016; 101: 2892-904.
 
10.
Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006; 29: 507-38.
 
11.
Linher-Melville K, Li J. The roles of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor and nerve growth factor during the final stage of folliculogenesis: a focus on oocyte maturation. Reproduction 2013; 145: R43-54.
 
12.
Ciesielska U, Piotrowska A, Kobierzycki C, et al. Comparison of TMA technique and routine whole slide analysis in evaluation of proliferative markers expression in laryngeal squamous cell cancer. In Vivo (Brooklyn) 2020; 34: 3263-70.
 
13.
Remmele W, Stegner HS. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987; 8: 138-40.
 
14.
Nowak M, Janas Ł, Soja M, et al. Chemokine expression in patients with ovarian cancer or benign ovarian tumors. Arch Med Sci 2021; 18: 682-9.
 
15.
Bianco B, Loureiro FA, Trevisan CM, et al. Effects of FSHR and FSHB variants on hormonal profile and reproductive outcomes of infertile women with endometriosis. Front Endocrinol 2021; 12: 760616.
 
16.
Rahmioglu N, Mortlock S, Ghiasi M, et al. The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditions. Nat Genet 2023; 55: 423-36.
 
17.
Bordoloi D, Bhojnagarwala PS, Perales-Puchalt A, et al. A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy. JCI Insight 2022; 22: e162553.
 
18.
Prabhudesai KS, Raje S, Dhamanaskar A, et al. Identification and in vivo validation of a 9-mer peptide derived from FSH with FSHR antagonist activity. Peptides 2020; 132: 170367.
 
eISSN:1896-9151
ISSN:1734-1922
Journals System - logo
Scroll to top